3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
11
Breast Neoplasms
10
Prostatic Neoplasms
7
Colorectal Neoplasms
7
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Hematopoietic and Lymphatic System Neoplasm
3
Hematologic Neoplasms
3
Advanced Malignant Solid Neoplasm
3
Skin Carcinoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Obesity-Related Malignant Neoplasm
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Malignant Solid Neoplasm
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Syndrome
1
Substance-Related Disorders
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Psoriasis
1
Primary Myelofibrosis
1
Interventions
Cyclophosphamide
16
fludarabine
9
Cytarabine
9
venetoclax
8
Mycophenolic Acid
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Tacrolimus
5
Daunorubicin
5
Cyclosporine
5
ruxolitinib
4
ponatinib
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
Etoposide
4
blinatumomab
3
asciminib
3
Vincristine
3
Prednisone
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Dexamethasone
3
Azacitidine
3
revumenib
2
quizartinib
2
pegfilgrastim
2
nilotinib
2
ibrutinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Educational Status
×
90 days
×
Clear all
No trials found.